Agree malmanu, AML is the big ticket of the ptx200 compound at the moment.
Currently, dosage trials via the phase 2 pilots may even enhance the original 1a mono therapy exceptional results..., hence potentially become the standard of care over the current chemo options.
So, discursive, if the above is the case then big Pharma will open their chequebook.
Time will tell.
PTX Price at posting:
7.0¢ Sentiment: Buy Disclosure: Held
